Connect with us

Politics

UK Gets One Step Closer To Medical Marijuana Legalization

Published

on

Marijuana has numerous therapeutic benefits and should be rescheduled under federal law, England’s top medical officer announced on Tuesday.

In a report reviewing the medical potential of cannabis, professor Sally Davies pointed to several health conditions the plant is known to treat. The list of maladies where there is “conclusive evidence” of marijuana’s therapeutic benefits includes chronic pain, chemotherapy-induced nausea and vomiting and muscle spasms due to multiple sclerosis.

There’s “moderate evidence” that marijuana can improve “short-term sleep outcomes” for individuals suffering from a wide range of other health conditions, according to the report.

“Schedule 1 drugs by definition have little or no therapeutic potential,” Davies concluded. “As summarized in this review, there is now conclusive evidence of medicinal benefit of cannabis based products for certain medical conditions, and reasonable evidence of benefit for indications that they may be useful under restricted circumstances.”

“My recommendation is that cannabis based medicinal products are moved out of Schedule 1 of the Misuse of Drugs Regulations 2001. It may be pragmatic for them all to be moved to Schedule 2 pending a fuller review by [the Advisory Council on the Misuse of Drugs] that can differentiate different products into the appropriate different Schedules.”

CMO Report Cannabis Products Web Accessible by MarijuanaMoment on Scribd

The report is part of a two-stage review of laws governing cannabis in England. Last month, the country’s interior ministry ordered the review—due in part to increased interest in reforming Britain’s marijuana laws in order to provide relief for patients. High-profile cases of children suffering from epilepsy being denied treatment ignited calls for reform.

In February, it was reported that lawmakers would take up debate over the country’s cannabis policy after the family of a six-year-old boy, Alfie Dingley, sought government approval to treat his severe epilepsy with marijuana. Prime Minister Theresa May (Conservative) rejected that appeal, however, and lawmakers ultimately ran out of time to vote on a proposed bill.

More recently, authorities confiscated a cannabis-based epilepsy medication from the mother of a 12-year-old boy at London’s Heathrow Airport. In a surprising win for patients and reform advocates, the government used “an exceptional power” to get the marijuana oil back to the family after the child was later admitted to the hospital for his severe seizures, Reuters reported.

What’s next?

Now that the chief medical officer has submitted her report outlining the therapeutic benefits of cannabis, the next step is for the Advisory Council on the Misuse of Drugs to review current marijuana laws and make a recommendation about its scheduling status. The review will take about three weeks, and if the recommendation aligns with the medical officer’s report, its likely that medical marijuana legalization will be on the horizon for England.

U.K. Home Secretary Sajid Javid said he ordered the second phase of the review based on the Davies’s report. Javid previously said that “[i]t has become clear to me since becoming home secretary that the position we find ourselves in currently is not satisfactory.”

“It is not satisfactory for the parent, it’s not satisfactory for the doctors and it’s not satisfactory for me,” he said, according to PoliticsHome. “I’ve now come to the conclusion that it is time to review the scheduling of cannabis.”

Canada’s Marijuana Legalization Bill Gets Final Approval From Lawmakers

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Kyle Jaeger is an LA-based contributor to Marijuana Moment. His work has also appeared in High Times, VICE, and attn.

Politics

Leading Congressional Marijuana Opponent In Danger Of Losing Seat, Polls Find

Published

on

U.S. Rep. Pete Sessions (R-TX) is facing his first major congressional reelection challenge in over a decade, and his opponent, Democratic candidate Colin Allred, is hot on his trail, according to recent polling.

For marijuana reform advocates, it’s a race to follow.

Sessions, as chairman of the House Rules Committee, has systematically blocked votes on cannabis-related legislation by his colleagues on Capitol Hill. Measures on everything from expanding access to medical marijuana for veterans to protecting legal cannabis states from federal interference have been dead upon arrival. Even hemp is a no-go with Sessions at the helm of the powerful committee.

Not a single cannabis-related vote has been allowed on the House floor during the current Congress, thanks to Sessions.

The closest the GOP congressman has come to compromise on the issue in recent months seems to be his pledge to continue talks with a medical marijuana advocacy group. Members of the organization told Marijuana Moment earlier this month that the congressman was “very receptive” to their mission when they met—but Sessions has yet to commit to backing any specific legislation.

But in November, voters in Texas’s 32nd Congressional District will have an opportunity to elect a representative with starkly different attitude toward drug policy: Allred, a civil rights attorney and former NFL player, supports medical cannabis and decriminalizing simple possession of marijuana.

A new poll from The New York Times poll shows a surprisingly tight race.

The Times called more than 43,000 voters across District 32 over the past week to get a sense of voter sentiment heading into November, talking to 500 of them. The results of those calls showed 48 percent of respondents supporting Sessions to Allred’s 47 percent.

Via The New York Times.

Of course, 500 isn’t an especially large sample size and the margin of error is about five percentage points.

But another recent survey conducted by Public Policy Polling for a healthcare advocacy group showed Allred ahead of the anti-cannabis incumbent by five points (47-42 percent).

Accordingly, the race has been graded as a “toss-up” by the Cook Political Report.

The apparent closeness of the contest is noteworthy. Fewer voters seem to have formed strong opinions about Allred, with almost 50 percent of respondents telling the Times they couldn’t say whether they had a favorable or unfavorable opinion of the candidate. Sessions, a known quantity as a sitting elected official, had a higher favorable rating (42 percent) than Allred, but also a significantly higher unfavorable rating (44 percent).

Respondents in the Times survey were also asked to weigh in on the U.S. Senate race between Sen. Ted Cruz (R-TX) and Rep. Beto O’Rourke (D-TX). Forty-nine percent of voters in Sessions’s district said they’d vote O’Rourke if the election was “being held today,” while 47 percent said they’d vote Cruz.

It’s hard to say how much each candidate’s position on cannabis will tilt the scales in November, but what is known is that a bipartisan majority of Texans side with Allred when it comes to marijuana reform. A 2017 survey found “83 percent of Texans support legalizing marijuana for some use,” for example.

Via the University of Texas/Texas Tribune.

More on Allred’s stance on marijuana policy.

Asked about his plans for veterans transitioning back to civilian life, who might be struggling with mental health issues, Allred said “[p]art of that care should be the legalization of medical marijuana and cannabis as a non-addictive alternative to opioids and to treat PTSD and other battlefield injuries.”

The candidate has also criticized Sessions for holding up cannabis legislation, writing it’s “unfortunate that Pete Sessions refuses to acknowledge that medical marijuana can help our veterans coming back from war who are struggling with PTSD and chronic pain.”

Marijuana In Texas: Where Ted Cruz And Beto O’Rourke Stand On Legalization

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Canadians Involved In Marijuana Industry Not Welcome In US, Feds Confirm

Published

on

As Canada inches closer to opening its retail marijuana market next month, U.S. border officials are officially laying out their policy of weeding out the country’s cannabis consumers as well as those who work or invest in the industry.

In a Friday press release, U.S. Customs and Border Protection (CBP) confirmed previous news reports and affirmed that border officials will continue to enforce U.S. federal law, which for decades has defined marijuana as having a high potential for abuse and no medical benefit.

“Canada’s legalization of marijuana will not change CBP’s enforcement of United States laws regarding controlled substances,” the statement reads.

But more than just stopping marijuana from crossing the border, the federal agency will also actively deny entry into the country by people who work in the legal cannabis industry.

“As marijuana continues to be a controlled substance under United States law, working in or facilitating the proliferation of the legal marijuana industry in U.S. states where it is deemed legal or Canada may affect admissibility to the U.S.,” reads the CBP statement.

Canada became the second nation in the world to legalize marijuana in June. Starting on October 17, Canadian adults will be able to purchase and consume cannabis legally.

Although 31 U.S. states and Washington, D.C. have legalized cannabis for medical use and nine states and D.C. allow recreational use—including Washington, Vermont and Maine, which sit along the Canadian border—CBP officials say that entering the country with marijuana, even into a legalized state, “may result in seizure, fines, and/or arrest and impact admissibility.”

CBP officials spoken about the anti-marijuana policy before, but with Friday’s press release it’s now officially in black and white.

In the eyes of the U.S. federal government, “we don’t recognize that as a legal business,” Todd Owen, executive assistant commissioner for CBP’s Office of Field Operations told Politico earlier this month.

The senior official also cautioned that travelers risk a “lifetime ban” if they lie about their past drug use. “Our officers are not going to be asking everyone whether they have used marijuana, but if other questions lead there—or if there is a smell coming from the car, they might ask,” he said.

Any traveler who admits to past use of illegal drugs, including marijuana, will not be allowed into the U.S. CBP will then keep a record of the traveler and prohibit them from returning, whether or not the individual has previously entered the country. If they wish to return, the traveler must apply for a waiver to lift the lifetime ban at a cost of $585, as reported by Politico.

In response, Rep. Lou Correa (D-CA) demanded that Homeland Security Secretary Kirstjen Nielsen clarify her department’s policy and how it would go about enforcing it.

In a draft letter obtained by Marijuana Moment this month, the congressman posed a list of questions including how, exactly, the Department of Homeland Security will “evaluate and determine that an authorized foreign national is associated with the cannabis industry.”

Lawmaker Presses Trump Official On Banning Canadians From US For Marijuana

Photo courtesy of Gerald L. Nino, U.S. Department of Homeland Security.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Idaho Gubernatorial Candidates Disagree On Marijuana Legalization

Published

on

Marijuana is an increasingly prominent issue in many political races this year.

Even in campaigns where cannabis is not a central concern, the candidates are often taking strong positions on legalization when asked about it.

Here’s a look at where the major party contenders in Idaho’s gubernatorial contest stand on ending marijuana prohibition and related reforms.

Democrat: Paulette Jordan

While Jordan, a former state legislator and tribal council member, has focused more on decriminalization and medical cannabis during her campaign, she does support full marijuana legalization.

Jordan has touted her work on a decriminalization bill in the legislature, saying “I realize it’s baby steps in this state. But the fact of the matter remains that 70 percent of our borders are surrounded by states that have legalized marijuana.”

She tweeted, but later deleted, “I look forward to decriminalizing Cannabis and leading the way for medicinal cannabis as an alternative medicine that is taxed and well regulated.”

During a Democratic primary debate, she said there’s “nothing wrong” with legalization.

In a Facebook Live interview with the Idaho Statesman (roughly 10 minutes into the video below), she spoke about children who benefit from cannabidiol (CBD) oil, saying that marijuana is “a natural medicine that mother earth has created” and that has “been here for thousands of years, as long as my ancestors have been here.”

Addressing broader recreational legalization, she said, “the numbers that have been very beneficial to other states when it comes down to resources for education.”

Republican: Brad Little

Currently the state’s lieutenant governor and a former state lawmaker, Little opposes legalization but does support limited CBD medical cannabis access.

“I support existing Idaho law and oppose the legalization of marijuana,” he said during a Republican primary debate, criticizing a legislative proposal to expand on the existing CBD pilot program established by current Gov. Butch Otter (R).

“We are expanding the current quality controlled CBD oil treatment study taking place where CBD oil is being administered to children with epilepsy or seizure disorders, and the results seem to be proving very successful. I support this pilot, and I want to ensure that we get all the data and know that this treatment works,” he said. “As for this session’s CBD legislation, I think it was far too broad and had too many unintended consequences.”

He previously argued that the state’s limited CBD oil program is “working” and advocated for restrictive restrictive regulations on CBD during another debate.

The Idaho Republican Party tweeted about Little’s opposition (and Jordan’s support for) “fully legalizing all marijuana.”

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox